Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-26-007962
Filing Date
2026-01-09
Accepted
2026-01-08 19:00:45
Documents
20

Document Format Files

Seq Description Document Type Size
1 424B5 d52868d424b5.htm 424B5 822595
2 EX-FILING FEES d52868dexfilingfees.htm   iXBRL EX-FILING FEES 22675
3 GRAPHIC g52868g05b01.jpg GRAPHIC 64248
4 GRAPHIC g52868g13j70.jpg GRAPHIC 30639
5 GRAPHIC g52868g18h30.jpg GRAPHIC 96533
6 GRAPHIC g52868g21x92.jpg GRAPHIC 55459
7 GRAPHIC g52868g77o56.jpg GRAPHIC 54231
8 GRAPHIC g52868g81p57.jpg GRAPHIC 56422
9 GRAPHIC g52868g88d66.jpg GRAPHIC 55790
10 GRAPHIC g52868g92y09.jpg GRAPHIC 55534
  Complete submission text file 0001193125-26-007962.txt   1624543

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT d52868dexfilingfees_htm.xml XML 7420
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-292061 | Film No.: 26521016
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)